Early phase I data presented for LVGN-6051 as monotherapy and in combination with pembrolizumab June 17, 2021 No Comments
China's NMPA approves initiation of clinical trials of anti-Claudin 18.2 ADC SYSA-1801 June 17, 2021 No Comments
Apexigen and NSGO-CTU to collaborate on phase II study of sotigalimab for ovarian cancer June 17, 2021 No Comments
MacroGenics and Zai Lab collaborate on bispecific molecules in immuno-oncology June 17, 2021 No Comments
Harbour BioMed and Dana-Farber Cancer Institute to codevelop novel biotherapies for cancer June 16, 2021 No Comments
RSS